Charcot-Marie-Tooth Disease – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Charcot-Marie-Tooth Disease – Drugs In Development, 2024 report and make more profitable business decisions.
Charcot-Marie-Tooth disease (CMT) is a term for a group of inherited genetic disorders that affect the peripheral nerves, which connect the brain and spinal cord to the muscles and sensory organs. CMT causes progressive weakness, muscle wasting, and loss of sensation in the feet, legs, hands, and arms. It can also cause foot deformities such as high arches or flat feet. CMT usually begins in childhood or early adulthood, but symptoms can vary widely in severity and onset. There is no cure for CMT, but treatments can help manage the symptoms and maintain function.
The Charcot-Marie-Tooth Disease drugs in development market research report provide comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Charcot-Marie-Tooth Disease and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Charcot-Marie-Tooth Disease | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 50 molecules, with 42 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Charcot-Marie-Tooth Disease therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Charcot-Marie-Tooth Disease pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Charcot-Marie-Tooth Disease treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Actio Biosciences IncAcuraStem Inc
Addex Therapeutics Ltd
Affectis Pharmaceuticals AG
Ageronix SA
Alcyone Therapeutics Inc
Armatus Bio LLC
Augustine Therapeutics
Bristol-Myers Squibb Co
Cedars-Sinai Medical Center
Cellatoz Therapeutics Inc
Cyprus Institute of Neurology and Genetics
Elpida Therapeutics
Encell Co Ltd
GeneNet Co Ltd
Helixmith Co Ltd
Imnewrun Bioscience Co Ltd
InFlectis BioScience SAS
Ionis Pharmaceuticals Inc
Lead Discovery Center GmbH
MedDay SA
Mitochondria In Motion Inc
Nervosave Therapeutics
Neurogene Inc
NMD Pharma AS
Novartis AG
OliPass Corporation
Oryzon Genomics SA
PharmatrophiX Inc
Pharnext SA
Recursion Pharmaceuticals Inc
Regenacy Pharmaceuticals LLC
Samsara Therapeutics Inc
Sanofi
Shape Therapeutics Inc
Starwise Therapeutics LLC
ToolGen Inc
UGISense AG
University of Illinois at Chicago
University of Iowa
University of Pennsylvania
Washington University School of Medicine
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Charcot-Marie-Tooth Disease reports